SOLOFECTOR
DEAD

Serial Number

90514423

Owner

Basilard BioTech, Inc.

Attorney

Douglas Q. Hahn, Esq.

Filing Date

Feb 5, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SOLOFECTOR Trademark

Serial Number: 90514423

SOLOFECTOR is a trademark filed by Basilard BioTech, Inc. on February 5, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Basilard BioTech, Inc. (3 trademarks)

Suite #200, PMB #278
Temecula, CA 92590

Entity Type: 03

Trademark Details

Filing Date

February 5, 2021

Registration Date

Not Registered

Published for Opposition

May 17, 2022

Goods & Services

Scientific apparatus for engineering cells for scientific research use, namely, development of cell and gene therapy products and for delivery of exogenous cargo into cells, probes for scientific purposes; bioassay apparatus, namely, immune panels; measuring apparatus and instruments, namely, ex-vivo assays for characterization of engineering cells or viruses, other than medical; parts and fittings for the aforesaid goods

Engineered cells for medical or clinical use, namely, for creating cell and gene therapies for treatment of medical conditions; Cells for medical or clinical use; Living cells for medical use; Drug delivery agents in the form of medically engineered cells for use in targeted drug delivery for a wide variety of pharmaceuticals; medically engineered cells for medical use in targeted drug delivery for a wide variety of pharmaceuticals

Engineered cells for scientific and research use; medically engineered cells for scientific and research use in targeted drug delivery for a wide variety of pharmaceuticals

Apparatus for engineering cells for medical or clinical use, namely, modification and delivery of cells for near-patient use; medical apparatus and instruments for the modification and delivery of cells for near-patient use, for delivery of exogenous cargo into cells for creating cell and gene therapies for treatment of medical conditions; measuring apparatus and instruments for bioassay techniques for medical purposes; parts and fittings for the aforesaid goods

Research, development, and consulting services in cellular engineering

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 13, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 13, 2023 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 12, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 17, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 17, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 27, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 14, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 18, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 18, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 18, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 18, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 24, 2022 TEME
ASSIGNED TO LIE
Feb 24, 2022 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 23, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 4, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 4, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 4, 2021 CNRT
ASSIGNED TO EXAMINER
Aug 28, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 11, 2021 NWOS
NEW APPLICATION ENTERED
Feb 9, 2021 NWAP